Slide 1NAPLES Novel Approaches for Preventing or Limiting Event Study Randomised Comparison of Bivalirudin Monotherapy versus Unfractionated Heparin plus Tirofiban in Diabetic…

Slide 1NAPLES II Novel Approaches for Preventing or Limiting Event Study Impact of a Single High Loading Dose of Atorvastatin on Periprocedural Myocardial Infarction Carlo…

Slide 1Vinod H. Thourani, MD on behalf of The PARTNER Trial Investigators Three-Year Outcomes after Transcatheter or Surgical Aortic Valve Replacement in High- Risk Patients…

Slide 1Sandy Arner, RD, LDN Clinical Dietitian James H. Quillen VA Medical Center March 26, 2013 Slide 2 Disclosure Slides Financial Interest I, Sandra Arner, DO NOT have…

Slide 1NAPLES III Novel Approaches in Preventing or Limiting Event III TriaL Randomised Comparison of Bivalirudin versus Unfractionated Heparin in Patients at High Risk of…

Slide 1OPTIMIZE: A Prospective, Randomized Trial of 3 Months Versus 12 Months of Dual Antiplatelet Therapy with the Endeavor Zotarolimus-Eluting Stent Fausto Feres, MD, PhD…

Slide 1Measurement of Pain as the Fifth Vital Sign Dr Stephen Gilbert Scottish National Lead Clinician For Chronic Pain Slide 2 Disclosure Statement of Financial Interest…

1. The Spanish ESTROFA-2 registry Thrombosis in real practice with second generation Drug-eluting stents: Endeavor, Xience and Promus Jose Mª de la Torre Hernandez, MD,…

1. Evidence/Practice Intersection: How I Approach Thrombus in My Daily Clinical Practice (and Why) SOLACI in Partnership with TCT: Snapshot of Latin America Practice and…

1. @tedvickey #FOTTechnology's Approaching Impact on the Fitness Industry Ted Vickey President – FitWell ACE Senior Consultant – Emerging Technology…